Expert medical advice from the Chairman of the Cleveland Clinic Taussig Cancer Institute. Every year, 60,000 people are diagnosed with bladder cancer. If found early, bladder cancer is highly treatable,but it does have a high rate of recurrence. Staying informed is key for those facing a diagnosis as well as for those living with the disease.
Dr. Derek Raghavan is one of the country’s leading experts in this field and, as the Chairman of the Cleveland Clinic Taussig Cancer Institute, he has access to the latest research and studies. In The Cleveland Clinic Guide to Bladder Cancer, he provides all of the essential information needed to understand and manage the challenges of bladder cancer.
Derek Raghavan, MD, PhD, FACP, FRACP, is Chair and Director of Cleveland Clinic Taussig Cancer Institute, and holds the M. Frank & Margaret Domiter Rudy Distinguished Chair in Translational Cancer Research. He is an internationally recognized authority on cancer, has published extensively on the topic, and has advised on cancer research strategy for the European Organisation for Research and Treatment of Cancer, many US cancer centers, Cancer Research UK, and the German Cancer Fund.
Kathleen Tuthill is a medical writer and former newspaper reporter who has received numerous writing awards. She lives in the Cleveland area.